Human iPSC-based modeling of late-onset disease via progerin-induced aging

Miller, Justine D., Ganat, Yosif M., Kishinevsky, Sarah, Bowman, Robert L., Liu, Becky, Tu, Edmund Y., Mandal, Pankaj K., Vera, Elsa +9 more·2013·Cell stem cell
DOI 10.1016/j.stem.2013.11.006

Cited by (783)

Items 701–783 of 783

  1. Faculty Opinions recommendation of A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation.
    Yi Eve Sun, Weihong Ge · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  2. Editorial
    Roger Thomas · 2016 · Physiology News
  3. Thomas Hardye School student wins ‘Women in Physiology’ competition
    2016 · Physiology News
  4. From the archives: the cost-free joys of email
    2016 · Physiology News
  5. Faculty Opinions recommendation of Translational potential of human brain organoids.
    Alysson Renato Muotri · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  6. From the Archives: reports of the Sheffield, Mill Hill and Nuffield Institute meetings of 1965
    2016 · Physiology News
  7. Faculty Opinions recommendation of Applications of human brain organoids to clinical problems.
    Alysson Renato Muotri · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  8. Policy Focus
    2016 · Physiology News
  9. Bibliography
    2018 · Elsevier eBooks
  10. Envejecimiento cardiaco humano: transcriptómica y desarrollo de modelos celulares de envejecimiento
    Laura García‐Mendívil, Natalia Hernández Bellido, Marcos Sánchez Barat, María Pérez Zabalza, Elisa Garrido Huéscar, Juan Carlos Oliveros, Rafael Torres‐Pérez, Estel Ramos-Marquès, Esther Pueyo, Laura Ordovás · 2021 · Jornadas de jóvenes investigadores del I3A
  11. Cell therapy and biomanufacturing using hiPSC-derived neurons
    Juan Cruz Casabona · 2022 · Elsevier eBooks
  12. Advantages and limitations of hiPSC-derived neurons for the study of neurodegeneration
    Swati Mishra, Coen Van Deursen, Aiko Robert, Rik van der Kant, Jessica E. Young · 2022 · Elsevier eBooks
  13. Epigenetic aging and its reversal
    Cristina de la Parte, Diana Guallar · 2022 · Elsevier eBooks
  14. A simple, flexible, and high‐efficiency western blot analysis for age‐related human induced neurons
    Yanfei Shen, Mingjie Liu, Long Zhu, Xiaobang Shi, Meng‐Lu Liu · 2023 · Biotechnology Journal
  15. Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
    Amélie Weiss, Peter Sommer, Johannes H. Wilbertz · 2023 · Journal of Visualized Experiments
  16. Alpha-synuclein-associated alterations at the synapse in models of Parkinson’s disease
    Patrícia I. Santos · 2023
  17. Disease related changes in ATAC-Seq of more than 450 iPSC-derived motor neuron lines from ALS patients and controls
    Stanislav Tsitkov, Kelsey Valentine, Velina Kozareva, Aneesh Donde, Aaron P. Frank, Susan Lei, Jennifer E. Van Eyk, Steven M. Finkbeiner, Jeffrey D. Rothstein, Leslie Michels Thompson et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Stem Cell-Based Therapy for Parkinson’s Disease
    Ryan Brice, Haneesha Vishwa Sai, Kimmy Tran, Jade Garcia, Edwyne Ramirez, Yao Li · 2023 · Springer eBooks
  19. An Unconventional Mechanism of IL-1β Secretion that Requires Type I IFN in SLE Monocytes
    Simone Caielli, Preetha Balasubramanian, Juan F. Rodríguez-Alcázar, Uthra Balaji, Lauren A. Robinson, Zurong Wan, Jeanine M. Baisch, Cynthia Smitherman, Lynnette Walters, Paola R. Sparagana et al. · 2023 · SSRN Electronic Journal
  20. Additional file 5 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  21. Additional file 2 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  22. Additional file 4 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  23. Additional file 3 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  24. Partial Cell Reprogramming as a Method of Revitalizing Living Systems
    Mariia Shorokhova · 2023 · Tsitologiya
  25. Roles of Ipsc in Advancing Treatments for Neurological Disorders
    Xinran Zhang · 2024 · SSRN Electronic Journal
  26. Stem Cell-Based Therapy for Parkinson’s Disease
    Ryan Brice, Haneesha Vishwa Sai, Kimmy Tran, Jade Garcia, Edwyne Ramirez, Yao Li · 2024 · Springer eBooks
  27. Neural cells derived from pluripotent stem cells and directly induced from somatic cells
    Hideyuki Okano, Wado Akamatsu · 2024 · Elsevier eBooks
  28. Aging and rejuvenation of engineered cardiovascular tissues: from research to clinical application
    Chang Xin Liu, Jing Guo, Yanan Zhang, Meiyu Hu, Tian Hao, Dragoş Crețoiu, Guoping Li, Junjie Xiao · 2024 · The Journal of Cardiovascular Aging
  29. Application of Stem Cells to Understanding Psychiatric Disorders
    Marcella Birtele, Giorgia Quadrato, Kristen Brennand · 2025 · Oxford University Press eBooks
  30. Long‐Term Post‐Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti‐Aging Compounds
    Larissa Traxler, Lukas Karbacher, Oliver Borgogno, Taylor Ozbun, Kylie Champion, Anna S. Smaling, Lucia Zhou-Yang, Joseph R. Herdy, Lena Böhnke, Barbara C. Böckle et al. · 2026 · Aging Cell
  31. The potential of brain organoids in addressing the heterogeneity of synucleinopathies
    Xiao-Jun Diao, Claudio A. Soto, Fei Wang, Yu Wang, Yun‐Cheng Wu, Abhisek Mukherjee · 2025 · Cellular and Molecular Life Sciences
  32. Nanotechnology & human stem cells : applications in cardiogenesis and neurogenesis
    Martin L. Tomov · 2016
  33. The Role of Progerin in Artificially Ageing Stem Cells
    Rachel Brown, Mubeen Goolam · 2025 · Stem Cell Reviews and Reports
  34. Lonafarnib Partially Reverses Cardiac Senescence in Human and Mouse Progeria Models via Autophagy Activation
    Luís Miguel Monteiro, Patrícia R. Pitrez, Simão Correia-Santos, Nicola Dark, Deolinda R. Santinha, Célia Alexandra Aveleira, Megan Townsend, James Taylor, Xavier Nissan, Vilma A. Sardão et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Expression of progerin enhances disease-related endpoints in a tau seeding reporter cell system
    Zhuang Zhuang Han, Sang‐Gyun Kang, Erik Gomez‐Cardona, Serene L. Wohlgemuth, Klinton Shmeit, Luis Arce, Jiri Safar, Olivier Julien, David A. Westaway · 2025 · GeroScience
  36. Genome Editing and Human-Induced Pluripotent Stem Cells Facilitate Parkinson’s Disease Modeling
    Catalina M. Polanco, José Inzunza, Ivan Nalvarte, Jonathan Arias · 2025 · Stem cell biology and regenerative medicine
  37. The Application of Directly Induced Neurons to Neurodegenerative Disease Research
    Sumihiro Maeda · 2025 · Stem cell biology and regenerative medicine
  38. Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
    Marta González-Sepúlveda, Joana M. Cladera-Sastre, Miquel Vila · 2025 · Handbook of behavioral neuroscience
  39. Additional file 6 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Nissim-Rafinia, Malka, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  40. Additional file 1 of Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Nissim-Rafinia, Malka, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Figshare
  41. Additional file 1 of Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease
    Junjiao Wu, Ren, Jie, Hongfei Cui, Xie, Yali, Tang, Yu · 2024 · Figshare
  42. ER-diffusion barriers exist in hematopoietic stem cell mitoses, but are not required for lysosomal asymmetric cell division
    Florin Schneiter, Dirk Loeffler, Timm Schroeder · 2025 · Experimental Hematology
  43. Modeling sporadic Alzheimer’s disease using brain organoids: Emerging trends and translational opportunities
    Muhammad Kamal Hossain, Hyung‐Ryong Kim · 2026 · Tissue and Cell
  44. Aging in 3D: Organoid Systems as Models to Uncover Cellular Senescence and Therapeutic Targets Across Diseases
    Shilpa Bisht, Paras Varshney, Abhishek Gupta · 2026 · Targets
  45. Evaluation expérimentale du risque prion lié aux porteurs asymptomatiques chez l'Homme et le macaque
    Jessica Rontard · 2018 · theses.fr (ABES)
  46. Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
    Laura Auboyer · 2018 · theses.fr (ABES)
  47. Etude de mécanismes de type prion impliqués dans la maladie d’Alzheimer sur un modèle de mini-cerveaux humains avec exploration par microscopie 3D
    Férid Nassor · 2019 · theses.fr (ABES)
  48. Les agrégats de PABPN1 dans la dystrophie musculaire oculopharyngée
    Fanny Roth · 2019 · theses.fr (ABES)
  49. Recherche de médicaments à partir de dérivés neuronaux issus de cellules souches pluripotentes humaines porteuses de la mutation causale de la maladie de Huntington
    Julie Bigarreau · 2019 · theses.fr (ABES)
  50. Validation in vivo de l'implication de nouveaux gènes impliqués dans le développement musculaire des mammifères
    Louise Hélary · 2019
  51. Automatisation de la différenciation des cellules souches pluripotentes humaines en cellules de l’épithélium pigmentaire rétinien et modélisation des symptômes rétiniens associés à la mutation d’APC
    Florian Régent · 2018
  52. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022 · theses.fr (ABES)
  53. Impact de l'haplo-insuffisance de HIRA sur l'organisation de la chromatine au cours de la différenciation neuronale
    Jean-Philippe Trani · 2022 · theses.fr (ABES)
  54. Étude de la forme sporadique de la maladie d'Alzheimer à partir de modèles in vivo et de neurones humains reprogrammés
    Camille Thiberge · 2023 · theses.fr (ABES)
  55. Functional impacts of Huntingtin lowering on the synaptic maturation and activity of neuronal networks derived from human induced pluripotent stem cells
    Mathilde Louçã · 2024 · theses.fr (ABES)
  56. Intermolecular 3′UTR-3′UTR interactions drive Wnt gene activation through heteromeric protein assembly
    Ting Cai, Nelly M. Cruz, Sudipto Basu, Richard Mark White, Christine Mayr · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  57. iPSC Models of Hereditary Cancer Predisposition Syndromes: Mechanistic Pathways to Tumour Progression and Early Intervention
    蓓蓓 甘 · 2026 · Advances in Clinical Medicine
  58. Ginkgo Biloba Extract Ameliorates Age-Related Mitochondrial Deficits in Human iPSCs and Their Derived Neurons and Astrocytes
    Imane Lejri, Amandine Grimm, Anne Eckert · 2026 · Antioxidants
  59. Novel advanced patient-derived in vitro models of pediatric movement disorders to develop personalized therapeutic strategies
    S Yeadon, Ainara Salazar‐Villacorta, Manju A. Kurian, Serena Barral · 2026 · Frontiers in Neurology
  60. Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?
    Satoru Morimoto, Hideyuki Okano · 2026 · Expert Opinion on Drug Discovery
  61. Using human 3D organoid models to gain mechanistic insight in motor neuron diseases
    Benedetta Frizzi, Adriana Margarida Barbosa Correia, Irene Faravelli, Ludo Van Den Bosch, Stefania Paola Corti · 2026 · Nature reviews. Neuroscience
  62. Rodent models and accompanying in vitro strategies for studying the etiology and therapy of Parkinson's disease
    Kristina Lau, Tiago F. Outeiro, Franziska Richter · 2026 · Journal of Parkinson s Disease
  63. Applications in Modern Research
    Simone Badal · 2026 · Springer eBooks
  64. Human Stem Cell-Derived Models of the Alzheimer’s Disease Neuroimmune System
    Rose Summers, Daphne Quang, Noah R. Johnson · 2026 · International Journal of Molecular Sciences
  65. Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness
    Anuj Guruacharya, Thomas Härtung, Roberta Souza dos Reis, Natália Chermont dos Santos Moreira, Liliana Attisano, Silvia Bolognin, Khalid Iqbal, Binita Rajbanshi · 2026 · Stem Cell Reports
  66. Differential amyloid-beta sensitivity across human and nonhuman primate neurons
    Isabel August, Sheila Steiner, Ruth Oefner, Maria Carolina Marchetto · 2026 · Journal of Human Evolution
  67. Solute carrier membrane transporters: emerging targets in CNS disorders
    Yee Kwan Law, Selene Glück, Enrico Girardi, Ariel Bensimon, S. Andreas Angermayr, Giulio Superti‐Furga · 2026 · Nature Reviews Drug Discovery
  68. Beyond phenotypic markers: rethinking dopaminergic identity in iPSC-derived neurons
    Duc‐Hiep Bach, Thanh Liem Nguyen · 2026 · Cell Communication and Signaling
  69. Characterization of DNA methylation in PBMCs and donor-matched iPSCs shows age-related methylation is reset during stem cell reprogramming
    Xylena Reed, Cory A. Weller, Sara Sáez-Atiénzar, Alexandra G. Beilina, Sultana Solaiman, Makayla Portley, Mary Kaileh, Roshni Roy, Jinhui Ding, A. Zenobia Moore et al. · 2026 · PLoS ONE
  70. High-resolution genomic architecture of a 1.71-Mb inverted SNCA triplication in a patient-derived PARK4 model
    Atsushi Okano, Fuyuki Miya, Kenjiro Kosaki, Jin Nakahara, Daisuke Ito · 2026 · Biochemical and Biophysical Research Communications
  71. An age-preserving neuronal iSpheroid platform for modeling human aging and Alzheimer’s disease
    Samhan Alsolami, Meiyan Wang, Thaís S. Sabedot, Upendra Singh, Brian Kirk, Lisa E. Mitchell, Melissa Hernandez, Nicholas J. Skvir, Chynna Bowman, Kotaro Oiwa et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  72. From Amyloid Exposure to Genetic Causality: Converging hiPSC-Based Models of Alzheimer’s Disease
    Fiorella Colasuonno, Alessio Valenza, Federica Rossin, Sandra Moreno · 2026 · Cells
  73. Motor Neuron Disease in a Dish: The Power of Human Induced Pluripotent Stem Cell-Derived Spinal Motor Neurons and Glial Cells
    Martina Morrone, Chiara F. Valori, Liliana Brambilla, Daniela Rossi · 2026 · Cells
  74. Protracted Fate Acquisition and Epigenetic De‐Aging During Induced Neural Stem Cell Conversion of Human Blood Cells
    Lea Jessica Berg, Julia Franzen, Andreas Buneß, Rachel Konang, Chao Sheng, Michael Peitz, Andreas Till, Wolfgang Wagner, Oliver Brüstle · 2026 · Aging Cell
  75. Engineering the geriatric heart to model HFpEF
    Sebastian Bass-Stringer, Jarmon G. Lees, Shiang Yong Lim · 2026 · Heart Failure Reviews
  76. Organoids in drug discovery and development: emerging technologies to transition beyond animal models
    Jolene Phelps, Amanda Orr, Stephanie Michelle Willerth · 2026 · Expert Opinion on Drug Discovery
  77. Engineered peroxisomes and patient-derived iPSC models as potential biomaterial platforms for precision neuroprotection in oxidative stress-driven central nervous system disorders
    Csaba Matta, Yoon-Hee Cheon, Judit Vágó, Zoltán Mészár, Ee Hyun Kim, Songling Jiang, Andrea Balogh, Melinda Zana, András Dinnyés, Eun‐Jung Jin · 2026 · Materials Today Bio
  78. Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging
    Shijie Wang, Lisa Elia, Weiyi Liu, Steven M. Finkbeiner · 2026 · Journal of Clinical Investigation
  79. Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery
    Anja Harej, Valentino Rački, Andrej Belančić, Jasna Križ, Dinko Vitezić, Jasenka Mršić‐Pelčić, Ganesh Acharya, Mukesh Varshney, Kristina Pilipović · 2026 · Stem Cells International
  80. iPSC-derived RPE as a context-of-use defined NAM framework for RPE-centered drug-induced retinal toxicity assessment
    Weixiao Ding, Longjun Gu, 董田甜, Minjun Xiong, Chen Wang, Chunlei Ji, Juan Lv, Xuefeng Zhang, Xinjiang Gong · 2026 · Frontiers in Pharmacology
  81. Neuromuscular junction pathology in amyotrophic lateral sclerosis and emerging molecular therapeutic strategies
    Kazuki Okoshi, Yoshitsugu Aoki · 2026 · Journal of Human Genetics
  82. Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions
    Yeoheung Yun, Satarupa Jena, Hailey Egido-Betancourt, Samuel Uzoechi, Doo Yeon Kim, Jin-Moo Lee, Juliane Nguyen · 2026 · Advanced Drug Delivery Reviews
  83. Modelling Hereditary Spastic Paraplegias using Human Pluripotent Stem Cells
    Kyle R. Denton · 2015 · OpenCommons - UConn (University of Connecticut)